Kintor’s GT20029 Phase 1 success
    Update 12/5/2022

    At a glance
    In this general discussion post, the primary subjects mentioned are
    💧 GT20029 (topical) infrequent
    💧 Pyrilutamide (topical) 6 months
    💧 Finasteride (topical) microdosed
    💧 Minoxidil (topical)
    💧 RU58841 (topical) 6 months
    the tone is 😀 positive.

    Other terms

    Kintor's GT20029, a treatment for hair loss, has completed Phase 1 successfully, showing promise as an androgen receptor degrader that could potentially regrow hair. It is considered more effective than Pyrilutamide, with infrequent dosing and minimal systemic absorption.
    View this post in the Community →

    Similar Community Posts Join

    5 / 215 results

    Related Research

    5 / 5 results